ICM
CLF icon

Invenomic Capital Management’s Cleveland-Cliffs CLF Stock Holding History

Invenomic Capital Management’s Portfolio CLF Stock Details CLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-58,103
Closed -$1.26M – 161
2021
Q4 		$1.26M Buy
+58,103
New +$1.25M 0.27% 98

Other funds holding CLF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invenomic Capital Management's CLF Position: Q1 2022 in Review

Invenomic Capital Management sold out of Cleveland-Cliffs (CLF) in Q1 2022, closing a stake of 58,103 shares — an estimated $1.26M sold.

Invenomic Capital Management first reported a position in CLF in Q4 2021 and held it in 1 quarter. The position peaked at $1.26M in Q4 2021. 648 funds tracked by Wall St. Rank hold CLF as of Q1 2022.

  • Invenomic Capital Management reported no remaining Cleveland-Cliffs position as of Q1 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 58,103 Cleveland-Cliffs shares in Q1 2022, an estimated $1.26M.
  • Invenomic Capital Management first reported a position in Cleveland-Cliffs in Q4 2021 and held it in 1 quarter.
  • Invenomic Capital Management's Cleveland-Cliffs position peaked at $1.26M in Q4 2021.
  • 648 funds tracked by Wall St. Rank held Cleveland-Cliffs as of Q1 2022.

Based on Invenomic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.